SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Monday reported a loss of $57.5 million in its fourth quarter.
The Salt Lake City-based company said it had a loss of 31 cents per share.
The biotechnology company posted revenue of $13.7 million in the period.
For the year, the company reported a loss of $239.5 million, or $1.36 per share. Revenue was reported as $39.8 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.